Dr. Devon Webster,
Sometime back you wrote about upcoming trials by Tumor Vaccine Group at the University of Washington for patients who are NOT HLA-A2 positive. I found a dHER2 trial outside USA called
Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-Positive Metastatic Breast Cancer, (Clinical Trials.gov Identifier NCT00140738 by GlaxoSmithKLine)
The URL is:
http://www.clinicaltrials.gov/ct/show/NCT00140738;jsessionid=61EA362938EAD65BC5B716A044A 98B4F?order=47
Could you please let me know if the above are all related, or throw some light where it is held in USA?.
Regards,
Uma